Article
Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients.
Journal of medical virology - 1 Jul 2017
Murakawa Miyako, Asahina Yasuhiro, Kawai-Kitahata Fukiko, Nakagawa Mina, Nitta Sayuri, Otani Satoshi, Nagata Hiroko, Kaneko Shun, Asano Yu, Tsunoda Tomoyuki, Miyoshi Masato, Itsui Yasuhiro, Azuma Seishin, Kakinuma Sei, Tanaka Yasuhito, Iijima Sayuki, Tsuchiya Kaoru, Izumi Namiki, Tohda Shuji, Watanabe Mamoru
Abstract excerpt
Single nucleotide polymorphisms (SNPs) within or near interferon lambda 4 (IFNL4) gene located upstream of IFNL3 are associated with response to anti-HCV therapy both in interferon (IFN)-based and IFN-free regimens. IFNL4 encodes IFNλ4, a newly discovered type III IFN, and its expression is controlled by rs368234815-TT/ΔG, which is in strong linkage disequilibrium (LD) with other tag SNPs within or near IFNL4...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
